Discovery of a 4-arylaminoquinoline lead with potent in vivo anti-melanoma efficacy
Bioorganic Chemistry · 2026-12 · 185 · 110718
DOI: 10.1016/j.bioorg.2026.110718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-12. Verfasst von Yan Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Fuzhou University, Fuzhou, Fujian 350…. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Fuzhou University - Yishan Campus.
Abstract (Originalsprache)
Despite extensive studies on 4-arylaminoquinoline derivatives, systematic structure-activity relationship (SAR) governing the A-ring size, N-tosyl (NTs) group, B-site aniline substitution, and C-2 modification remains poorly defined. To address this, we designed a focused library with systematic structural variations at these positions. In vitro screening against highly metastatic B16/F10 melanoma cells identified compound 12 (five-membered A-ring, no NTs, B-fluoro, C-2 methoxy) as the most potent analogue, with an IC50 of 0.15 μM, superior to the lead FZU-0055-303 (0.23 μM) and doxorubicin (DOX, 0.53 μM). SAR studies revealed that the five-membered fused A-ring is optimal; the NTs group is generally unfavorable; a single B-fluoro is preferred; and the C-2 methoxy is critical for activity. Mechanistically, compound 12 induced mitochondrial membrane potential loss and cell death consistent with mitochondrial apoptosis, and inhibited B16/F10 cell migration. Network pharmacology and molecular docking further suggested Src and other cancer-related signaling proteins as potential targets. In a B16/F10 xenograft mouse model, intraperitoneal administration of compound 12 at 10 mg/kg significantly suppressed tumor growth without causing body weight loss or histopathological damage. Collectively, this work systematically refines the SAR of this scaffold, demonstrating that compound 12 exhibits low toxicity and holds promise as a novel anti-melanoma lead candidate for further development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Chemistry, Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Fuzhou University, Fuzhou, Fujian 350116, China.
- College of Chemistry, Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Fuzhou University, Fuzhou, Fujian 350116, China. Electronic address: hellogaoyu@126.com.
- College of Chemistry, Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), Fuzhou University, Fuzhou, Fujian 350116, China. Electronic address: chenhaij@gmail.com.
Förderung
- Fuzhou University - Yishan Campus
Zitieren
APA
Sun, Y., Zheng, X., Sun, X., Tan, D., Gao, Y., & Chen, H. (2026). Discovery of a 4-arylaminoquinoline lead with potent in vivo anti-melanoma efficacy. Bioorganic Chemistry, 185, 110718. https://doi.org/10.1016/j.bioorg.2026.110718
Vancouver
Sun Y, Zheng X, Sun X, Tan D, Gao Y, Chen H. Discovery of a 4-arylaminoquinoline lead with potent in vivo anti-melanoma efficacy. Bioorganic Chemistry. 2026;185:110718. doi:10.1016/j.bioorg.2026.110718
BibTeX
@article{Sun2026,
author = {Sun, Yan and Zheng, Xiaoshan and Sun, Xianbin and Tan, Ding and Gao, Yu and Chen, Haijun},
title = {Discovery of a 4-arylaminoquinoline lead with potent in vivo anti-melanoma efficacy},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {185},
pages = {110718},
doi = {10.1016/j.bioorg.2026.110718}
}
EUVIMED